Cargando…

Role of Sphingolipid Signaling in Glomerular Diseases: Focus on DKD and FSGS

Sphingolipids are well-recognized as major players in the pathogenesis of many human diseases, including chronic kidney disease. The kidney is a very sensitive organ to alterations in sphingolipid metabolism. The critical issues to be addressed in this review relate to the role of sphingolipids and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mitrofanova, Alla, Drexler, Yelena, Merscher, Sandra, Fornoni, Alessia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480905/ https://www.ncbi.nlm.nih.gov/pubmed/32914148 http://dx.doi.org/10.33696/Signaling.1.013

Ejemplares similares

Podocyte Pathology and Nephropathy – Sphingolipids in Glomerular Diseases
por: Merscher, Sandra, et al.
Publicado: (2014)

Implications of Sphingolipid Metabolites in Kidney Diseases
por: Mallela, Shamroop kumar, et al.
Publicado: (2022)

New insights into renal lipid dysmetabolism in diabetic kidney disease
por: Mitrofanova, Alla, et al.
Publicado: (2021)

Use of Lipid-Modifying Agents for the Treatment of Glomerular Diseases
por: Ge, Mengyuan, et al.
Publicado: (2021)

The podocyte: glomerular sentinel at the crossroads of innate and adaptive immunity
por: Burke, George W., et al.
Publicado: (2023)

Mitochondrial Contribution to Inflammation in Diabetic Kidney Disease
por: Mitrofanova, Alla, et al.
Publicado: (2022)

Update on Diabetic Kidney Disease (DKD): Focus on Non-Albuminuric DKD and Cardiovascular Risk
por: Scilletta, Sabrina, et al.
Publicado: (2023)

Adenine crosses the biomarker bridge: from ‘omics to treatment in diabetic kidney disease
por: Drexler, Yelena, et al.
Publicado: (2023)

Compound effects of aging and experimental FSGS on glomerular epithelial cells
por: Schneider, Remington R.S, et al.
Publicado: (2017)

Generalizability of FIGARO‐DKD and FIDELIO‐DKD Trial Criteria to the US Population Eligible for Finerenone
por: Chiu, Nicholas, et al.
Publicado: (2022)

Glucose- and Non-Glucose-Induced Mitochondrial Dysfunction in Diabetic Kidney Disease
por: Ito, Marie, et al.
Publicado: (2022)

Sphingomyelin phosphodiesterase acid like 3B (SMPDL3b) regulates Perilipin5 (PLIN5) expression and mediates lipid droplet formation
por: Mallela, Shamroop Kumar, et al.
Publicado: (2022)

Therapeutic approach to FSGS in children
por: Gipson, Debbie S., et al.
Publicado: (2007)

The Vicious Cycle of Renal Lipotoxicity and Mitochondrial Dysfunction
por: Ge, Mengyuan, et al.
Publicado: (2020)

Novel Therapies for Alport Syndrome
por: Chavez, Efren, et al.
Publicado: (2022)

ABCA1 deficiency contributes to podocyte pyroptosis priming via the APE1/IRF1 axis in diabetic kidney disease
por: Ito, Marie, et al.
Publicado: (2023)

The role of lncRNAs in regulation of DKD and diabetes-related cancer
por: Cheng, Yawei, et al.
Publicado: (2022)

Empagliflozin reduces podocyte lipotoxicity in experimental Alport syndrome
por: Ge, Mengyuan, et al.
Publicado: (2023)

Detection of DKD stage 1 and treatment are essential
por: Futrakul, Narisa, et al.
Publicado: (2018)

Identification of glomerular and podocyte-specific genes and pathways activated by sera of patients with focal segmental glomerulosclerosis
por: Otalora, Lilian, et al.
Publicado: (2019)

Translational Aspects of Sphingolipid Metabolism in Renal Disorders
por: Abou Daher, Alaa, et al.
Publicado: (2017)

Finerenone in Black Patients With Type 2 Diabetes and CKD: A Post hoc Analysis of the Pooled FIDELIO-DKD and FIGARO-DKD Trials
por: Flack, John M., et al.
Publicado: (2023)

Management of Lupus Nephritis: New Treatments and Updated Guidelines
por: Avasare, Rupali, et al.
Publicado: (2023)

CCR2 antagonism leads to marked reduction in proteinuria and glomerular injury in murine models of focal segmental glomerulosclerosis (FSGS)
por: Miao, Zhenhua, et al.
Publicado: (2018)

Soluble CD40 ligand directly alters glomerular permeability and may act as a circulating permeability factor in FSGS
por: Doublier, Sophie, et al.
Publicado: (2017)

The 2021–2022 position of Brazilian Diabetes Society on diabetic kidney disease (DKD) management: an evidence-based guideline to clinical practice. Screening and treatment of hyperglycemia, arterial hypertension, and dyslipidemia in the patient with DKD
por: de Sá, João Roberto, et al.
Publicado: (2022)

FSGS: Diagnosis and Diagnostic Work-Up
por: Sprangers, Ben, et al.
Publicado: (2016)

The Impact of Histologic Variants on FSGS Outcomes
por: Meliambro, Kristin, et al.
Publicado: (2014)

Kidney outcomes with finerenone: an analysis from the FIGARO-DKD study
por: Ruilope, Luis M, et al.
Publicado: (2022)

Metabolism, Energetics, and Lipid Biology in the Podocyte – Cellular Cholesterol-Mediated Glomerular Injury
por: Merscher, Sandra, et al.
Publicado: (2014)

FSGS Recurrence in Adults after Renal Transplantation
por: Rudnicki, Michael
Publicado: (2016)

Cost-Effectiveness of Canagliflozin Added to Standard of Care for Treating Diabetic Kidney Disease (DKD) in Patients with Type 2 Diabetes Mellitus (T2DM) in England: Estimates Using the CREDEM-DKD Model
por: Willis, Michael, et al.
Publicado: (2020)

The Saudi Diabetic Kidney Disease study (Saudi-DKD): clinical characteristics and biochemical parameters
por: Al-Rubeaan, Khalid, et al.
Publicado: (2018)

Non-Albumin Proteinuria (NAP) as a Complementary Marker for Diabetic Kidney Disease (DKD)
por: Bae, Jaehyun, et al.
Publicado: (2021)

Novelty of Sphingolipids in the Central Nervous System Physiology and Disease: Focusing on the Sphingolipid Hypothesis of Neuroinflammation and Neurodegeneration
por: Ayub, Maria, et al.
Publicado: (2021)

2DKD: a toolkit for content-based local image search
por: DeVille, Julian S., et al.
Publicado: (2020)

Virtual Patient Simulation in DKD: Successful Strategy for Improving Recognition and Management
por: Larkin, Amy, et al.
Publicado: (2021)

Network Pharmacology-Based Prediction of Mechanism of Shenzhuo Formula for Application to DKD
por: Wang, Xinmiao, et al.
Publicado: (2021)

The pleiotropic roles of sphingolipid signaling in autophagy
por: Li, Y, et al.
Publicado: (2014)

The pleiotropic roles of sphingolipid signaling in autophagy
por: Li, Y, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_f4t4hof9g6ueftfvl4dia71fso